查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
過敏免疫療法的全球市場-成長，未來展望，競爭分析(2022年～2030年)
市場調查報告書
商品編碼
1149169

過敏免疫療法的全球市場-成長，未來展望，競爭分析(2022年～2030年)

Allergy Immunotherapy Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030
出版日期: | 出版商: Acute Market Reports | 英文 119 Pages | 商品交期: 最快1-2個工作天內

價格

全球過敏免疫療法的市場規模在2020年達到19億5,310萬美元，在2021年到2029年間的年複合成長率預測將為10.1％。比傳統治療方法成本效益高，中國和印度的基礎設施整備和工業化造成的大氣污染擴大，氣喘和過敏性鼻炎的增加，推動了過敏免疫療法市場的成長。

本報告提供全球過敏免疫療法市場相關調查分析，提供商務展望，市場動態，市場分析，企業簡介等系統性資訊。

目錄

第1章 序文

  • 報告的說明
    • 報告的目的
    • 對象者
    • 主要的產品
  • 市場區隔
  • 調查手法
    • 階段Ⅰ-2次調查
    • 階段Ⅱ-1次調查
    • 階段Ⅲ-專家的審查
    • 假設
    • 所採用的方法

第2章 摘要整理

  • 市場概述:全球過敏免疫療法市場
  • 全球過敏免疫療法市場(100萬美元)(2021年):過敏
  • 全球過敏免疫療法市場(100萬美元)(2021年):不同治療
  • 全球過敏免疫療法市場(100萬美元):各地區
  • COVID-19影響
  • 富有魅力的投資提案(2021年):各地區
  • 競爭分析
    • 主要的過敏免疫療法市場供應商的市場定位
    • 過敏免疫療法市場供應商採用的策略
    • 主要的產業策略

第3章 過敏免疫療法市場:商務展望和市場動態

  • 簡介
  • 全球過敏免疫療法市場金額(100萬美元)(2020年～2030年)
  • 市場動態
    • 推動市場要素
    • 阻礙市場要素
    • 主要課題
    • 主要的機會
  • 促進因素與阻礙因素的影響分析
  • Seesaw分析
  • 波特的五力分析
    • 供應商的力量
    • 買主的力量
    • 替代品的威脅
    • 新加入廠商業者的威脅
    • 競爭企業間的敵對關係
  • PESTEL分析
    • 政治
    • 經濟
    • 技術性
    • 法律
    • 社會

第4章 過敏免疫療法市場，美金(100萬)(2020年～2030年):過敏

  • 市場概要
  • 成長和收益分析:2021年和2030年的比較
  • 市場區隔
    • 食物過敏
    • 過敏性鼻炎
    • 皮膚過敏
    • 蟲蜇過敏
    • 其他的過敏(藥物過敏，眼過敏，乳膠過敏之類的)

第5章 過敏免疫療法市場，美金(100萬)(2020年～2030年):不同治療

  • 市場概要
  • 成長和收益分析:2021年和2030年的比較
  • 市場區隔
    • 皮下免疫療法(SCIT)
    • 舌下免疫療法(SLIT)

第6章 北美的過敏免疫療法市場，美金(100萬)(2020年～2030年)

第7章 英國及歐洲聯盟的過敏免疫療法市場，美金(100萬)(2020年～2030年)

第8章 亞太地區的過敏免疫療法市場，美金(100萬)(2020年～2030年)

第9章 南美的過敏免疫療法市場，美金(100萬)(2020年～2030年)

第10章 中東及非洲的過敏免疫療法市場，美金(100萬)(2020年～2030年)

第11章 企業簡介

  • ALK-Abello A/S
  • HAL Allergy Group
  • Circassia
  • Aimmune Therapeutics
  • Merck KGaA
  • Anergis
  • Biomay AG
  • Stallergenes Greer
  • DBV Technologies
  • Allergy Therapeutics
Product Code: 138665-08-22

Industry Outlook

Allergy immunotherapy market accounted for a market value of US$ 1,953.1 Mn in 2020 and is projected to grow at a CAGR of 10.1% during the forecast period from 2022 to 2030. Allergy immunotherapy helps to prevent or minimize allergic reactions and provide long-term benefit to patients. This therapy helps to increase immunological tolerance and changes the course of disease due to which demand for immunotherapy is increasing globally.

Subcutaneous immunotherapy (SCIT) is highly demanded treatment for allergic rhinitis & asthma as it provides long-term relief to the patients

SCIT is an effective therapy against allergic diseases as it delivers symptomatic relief by altering the effect of allergic reaction by focusing the basic mechanism of immunology. Thus, in 2020 SCIT identified as the largest allergy immunotherapy type that is preferred and adopted by most of the physicians. In addition to that, compared with conventional treatment the cost-effectiveness of SCIT is high and new molecules under trials will assist the overall growth of allergy immunotherapy.

Air pollution has increased due to infrastructural development & industrialization in China & India specifically assisting the growth in asthma & allergic rhinitis

The Asia Pacific is the fastest growing segment due to key driving factors such as rising prevalence & awareness related to allergic conditions, and industrialization & infrastructural development has increased air pollution in China & India. According to the World Health Organization (WHO), there has been significant growth in the prevalence of allergic rhinitis in Asia-Pacific within the last decade that has increased the economic burden. According to experts, the key factors responsible for sudden growth in allergic rhinitis is result of changing the environment, development in hygiene & reduced infections, and increasing cases of genetic complications.

This report also covers segments including data specific to major market trends, opportunities, drivers, and restraints, to gain precise information against global allergy immunotherapy market. The key market players analyzed in the report based on major attributes such as business strength, product portfolio, and important market strategies. The report also covers an attractive investment proposition based on the in-depth geographical research executed based on PESTEL analysis. The companies profiled in the report are Hollister Stier, Leti, WOLW Pharma, Aimmune Therapeutics, ALK-Abello A/S, Stallergenes Greer, Allergopharma, DBV Technologies, Allergy Therapeutics, Biomay AG, HAL Allergy Group, Circassia, and Merck KGaA, among others.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Allergy Immunotherapy market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Allergy Immunotherapy market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Allergy

  • Food Allergy
  • Allergic Rhinitis
  • Skin Allergy
  • Insect-bite Allergy
  • Other Allergies (Drug Allergy, Eye Allergy, Latex Allergy, etc.)

Treatment

  • Subcutaneous Immunotherapy (SCIT)
  • Sublingual Immunotherapy (SLIT)

Region Segment (2020-2030; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Global Impact of COVID-19 Segment (2020-2021; US$ Million )

  • Pre COVID-19 situation
  • Post COVID-19 situation

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Allergy Immunotherapy market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2030.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Allergy Immunotherapy market?
  • Which is the largest regional market for Allergy Immunotherapy market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Allergy Immunotherapy market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Allergy Immunotherapy market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Allergy Immunotherapy Market
  • 2.2. Global Allergy Immunotherapy Market, By Allergy, 2021 (US$ Million)
  • 2.3. Global Allergy Immunotherapy Market, By Treatment, 2021 (US$ Million)
  • 2.4. Global Allergy Immunotherapy Market, By Geography, 2021 (US$ Million)
  • 2.5. Impact of Covid 19
  • 2.6. Attractive Investment Proposition by Geography, 2021
  • 2.7. Competitive Analysis
    • 2.7.1. Market Positioning of Key Allergy Immunotherapy Market Vendors
    • 2.7.2. Strategies Adopted by Allergy Immunotherapy Market Vendors
    • 2.7.3. Key Industry Strategies

3. Allergy Immunotherapy Market: Business Outlook & Market Dynamics

  • 3.1. Introduction
  • 3.2. Global Allergy Immunotherapy Market Value, 2020 - 2030, (US$ Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers
    • 3.3.2. Market Restraints
    • 3.3.3. Key Challenges
    • 3.3.4. Key Opportunities
  • 3.4. Impact Analysis of Drivers and Restraints
  • 3.5. See-Saw Analysis
  • 3.6. Porter's Five Force Model
    • 3.6.1. Supplier Power
    • 3.6.2. Buyer Power
    • 3.6.3. Threat Of Substitutes
    • 3.6.4. Threat Of New Entrants
    • 3.6.5. Competitive Rivalry
  • 3.7. PESTEL Analysis
    • 3.7.1. Political Landscape
    • 3.7.2. Economic Landscape
    • 3.7.3. Technology Landscape
    • 3.7.4. Legal Landscape
    • 3.7.5. Social Landscape

4. Allergy Immunotherapy Market: By Allergy, 2020-2030, USD (Million)

  • 4.1. Market Overview
  • 4.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 4.3. Market Segmentation
    • 4.3.1. Food Allergy
    • 4.3.2. Allergic Rhinitis
    • 4.3.3. Skin Allergy
    • 4.3.4. Insect-bite Allergy
    • 4.3.5. Other Allergies (Drug Allergy, Eye Allergy, Latex Allergy, etc.)

5. Allergy Immunotherapy Market: By Treatment, 2020-2030, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 5.3. Market Segmentation
    • 5.3.1. Subcutaneous Immunotherapy (SCIT)
    • 5.3.2. Sublingual Immunotherapy (SLIT)

6. North America Allergy Immunotherapy Market, 2020-2030, USD (Million)

  • 6.1. Market Overview
  • 6.2. Allergy Immunotherapy Market: By Allergy, 2020-2030, USD (Million)
  • 6.3. Allergy Immunotherapy Market: By Treatment, 2020-2030, USD (Million)
  • 6.4.Allergy Immunotherapy Market: By Region, 2020-2030, USD (Million)
    • 6.4.1.North America
      • 6.4.1.1. U.S.
      • 6.4.1.2. Canada
      • 6.4.1.3. Rest of North America

7. UK and European Union Allergy Immunotherapy Market, 2020-2030, USD (Million)

  • 7.1. Market Overview
  • 7.2. Allergy Immunotherapy Market: By Allergy, 2020-2030, USD (Million)
  • 7.3. Allergy Immunotherapy Market: By Treatment, 2020-2030, USD (Million)
  • 7.4.Allergy Immunotherapy Market: By Region, 2020-2030, USD (Million)
    • 7.4.1.UK and European Union
      • 7.4.1.1. UK
      • 7.4.1.2. Germany
      • 7.4.1.3. Spain
      • 7.4.1.4. Italy
      • 7.4.1.5. France
      • 7.4.1.6. Rest of Europe

8. Asia Pacific Allergy Immunotherapy Market, 2020-2030, USD (Million)

  • 8.1. Market Overview
  • 8.2. Allergy Immunotherapy Market: By Allergy, 2020-2030, USD (Million)
  • 8.3. Allergy Immunotherapy Market: By Treatment, 2020-2030, USD (Million)
  • 8.4.Allergy Immunotherapy Market: By Region, 2020-2030, USD (Million)
    • 8.4.1.Asia Pacific
      • 8.4.1.1. China
      • 8.4.1.2. Japan
      • 8.4.1.3. India
      • 8.4.1.4. Australia
      • 8.4.1.5. South Korea
      • 8.4.1.6. Rest of Asia Pacific

9. Latin America Allergy Immunotherapy Market, 2020-2030, USD (Million)

  • 9.1. Market Overview
  • 9.2. Allergy Immunotherapy Market: By Allergy, 2020-2030, USD (Million)
  • 9.3. Allergy Immunotherapy Market: By Treatment, 2020-2030, USD (Million)
  • 9.4.Allergy Immunotherapy Market: By Region, 2020-2030, USD (Million)
    • 9.4.1.Latin America
      • 9.4.1.1. Brazil
      • 9.4.1.2. Mexico
      • 9.4.1.3. Rest of Latin America

10. Middle East and Africa Allergy Immunotherapy Market, 2020-2030, USD (Million)

  • 10.1. Market Overview
  • 10.2. Allergy Immunotherapy Market: By Allergy, 2020-2030, USD (Million)
  • 10.3. Allergy Immunotherapy Market: By Treatment, 2020-2030, USD (Million)
  • 10.4.Allergy Immunotherapy Market: By Region, 2020-2030, USD (Million)
    • 10.4.1.Middle East and Africa
      • 10.4.1.1. GCC
      • 10.4.1.2. Africa
      • 10.4.1.3. Rest of Middle East and Africa

11. Company Profile

  • 11.1. ALK-Abello A/S
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Portfolio
    • 11.1.4. Strategic Initiatives
  • 11.2. HAL Allergy Group
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Portfolio
    • 11.2.4. Strategic Initiatives
  • 11.3. Circassia
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Portfolio
    • 11.3.4. Strategic Initiatives
  • 11.4. Aimmune Therapeutics
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Portfolio
    • 11.4.4. Strategic Initiatives
  • 11.5. Merck KGaA
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Portfolio
    • 11.5.4. Strategic Initiatives
  • 11.6. Anergis
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Portfolio
    • 11.6.4. Strategic Initiatives
  • 11.7. Biomay AG
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Portfolio
    • 11.7.4. Strategic Initiatives
  • 11.8. Stallergenes Greer
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Portfolio
    • 11.8.4. Strategic Initiatives
  • 11.9. DBV Technologies
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Portfolio
    • 11.9.4. Strategic Initiatives
  • 11.10. Allergy Therapeutics
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Portfolio
    • 11.10.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Allergy Immunotherapy Market By Allergy, 2020-2030, USD (Million)
  • TABLE 2 Global Allergy Immunotherapy Market By Treatment, 2020-2030, USD (Million)
  • TABLE 3 North America Allergy Immunotherapy Market By Allergy, 2020-2030, USD (Million)
  • TABLE 4 North America Allergy Immunotherapy Market By Treatment, 2020-2030, USD (Million)
  • TABLE 5 UK and European Union Allergy Immunotherapy Market By Allergy, 2020-2030, USD (Million)
  • TABLE 6 UK and European Union Allergy Immunotherapy Market By Treatment, 2020-2030, USD (Million)
  • TABLE 7 Asia Pacific Allergy Immunotherapy Market By Allergy, 2020-2030, USD (Million)
  • TABLE 8 Asia Pacific Allergy Immunotherapy Market By Treatment, 2020-2030, USD (Million)
  • TABLE 9 Latin America Allergy Immunotherapy Market By Allergy, 2020-2030, USD (Million)
  • TABLE 10 Latin America Allergy Immunotherapy Market By Treatment, 2020-2030, USD (Million)
  • TABLE 11 Middle East and Africa Allergy Immunotherapy Market By Allergy, 2020-2030, USD (Million)
  • TABLE 12 Middle East and Africa Allergy Immunotherapy Market By Treatment, 2020-2030, USD (Million)

List of Figures

  • FIG. 1 Global Allergy Immunotherapy Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Allergy Immunotherapy Market: Quality Assurance
  • FIG. 5 Global Allergy Immunotherapy Market, By Allergy, 2021
  • FIG. 6 Global Allergy Immunotherapy Market, By Treatment, 2021
  • FIG. 7 Global Allergy Immunotherapy Market, By Geography, 2021
  • FIG. 8 Global Allergy Immunotherapy Market, By Allergy, 2021 Vs 2030, %
  • FIG. 9 Global Allergy Immunotherapy Market, By Treatment, 2021 Vs 2030, %
  • FIG. 10 U.S. Allergy Immunotherapy Market (US$ Million), 2020 - 2030
  • FIG. 11 Canada Allergy Immunotherapy Market (US$ Million), 2020 - 2030
  • FIG. 12 Rest of North America Allergy Immunotherapy Market (US$ Million), 2020 - 2030
  • FIG. 13 UK Allergy Immunotherapy Market (US$ Million), 2020 - 2030
  • FIG. 14 Germany Allergy Immunotherapy Market (US$ Million), 2020 - 2030
  • FIG. 15 Spain Allergy Immunotherapy Market (US$ Million), 2020 - 2030
  • FIG. 16 Italy Allergy Immunotherapy Market (US$ Million), 2020 - 2030
  • FIG. 17 France Allergy Immunotherapy Market (US$ Million), 2020 - 2030
  • FIG. 18 Rest of Europe Allergy Immunotherapy Market (US$ Million), 2020 - 2030
  • FIG. 19 China Allergy Immunotherapy Market (US$ Million), 2020 - 2030
  • FIG. 20 Japan Allergy Immunotherapy Market (US$ Million), 2020 - 2030
  • FIG. 21 India Allergy Immunotherapy Market (US$ Million), 2020 - 2030
  • FIG. 22 Australia Allergy Immunotherapy Market (US$ Million), 2020 - 2030
  • FIG. 23 South Korea Allergy Immunotherapy Market (US$ Million), 2020 - 2030
  • FIG. 24 Rest of Asia Allergy Immunotherapy Market (US$ Million), 2020 - 2030
  • FIG. 25 Brazil Allergy Immunotherapy Market (US$ Million), 2020 - 2030
  • FIG. 26 Mexico Allergy Immunotherapy Market (US$ Million), 2020 - 2030
  • FIG. 27 Rest of Latin America Allergy Immunotherapy Market (US$ Million), 2020 - 2030
  • FIG. 28 GCC Allergy Immunotherapy Market (US$ Million), 2020 - 2030
  • FIG. 29 Africa Allergy Immunotherapy Market (US$ Million), 2020 - 2030
  • FIG. 30 Rest of Middle East and Africa Allergy Immunotherapy Market (US$ Million), 2020 - 2030